What is the clinical evidence from this study?

Study design: Review. Population: Rheumatic heart disease.

What does this research mean for the field?

Antigenic mimicry between streptococcal M protein and cardiac proteins, combined with dysregulated immune control involving T-cell responses and cytokine networks, drives valvular injury in rheumatic heart disease. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To review the immunopathogenic mechanisms that drive the progression of acute rheumatic fever to chronic rheumatic heart disease and valvular injury following Streptococcus pyogenes infection.

September 1, 2026The Lancet MicrobeOpen Access

Mechanisms underlying rheumatic heart disease immune-mediated pathogenesis: T-cell responses, cytokine networks, and immune dysregulation as drivers of valvular injury

View Full Paper

Ask AI

Bookmark

Key result

Antigenic mimicry and dysregulated immunity drive RHD pathogenesis via T-cell, cytokine, and endothelial activation.

Why the study?

Chronic rheumatic heart disease is an under-recognised cause of cardiovascular morbidity and death needing clarification of its immunopathogenesis to inform earlier diagnosis, enhanced secondary prevention, and rational therapies.

Key Points

To review the immunopathogenic mechanisms that drive the progression of acute rheumatic fever to chronic rheumatic heart disease and valvular injury following Streptococcus pyogenes infection.
Reviewed published evidence regarding autoimmune cross-reactivity and cellular immune responses triggered by Streptococcus pyogenes.
Evaluated pathways of antigenic mimicry, T-cell recruitment, cytokine dysregulation, endothelial activation, and valvular tissue remodeling.
Antigenic mimicry between streptococcal M protein and host cardiac matrix proteins triggers cross-reactive T-cell responses that target heart valves.
Chemokine-guided immune infiltration, sustained cytokine networks, endothelial activation, and stromal remodeling promote persistent valvular damage.
Gaps in current understanding underscore the need for improved experimental models, validated diagnostic biomarkers, and specific immunomodulatory therapies.

Structured PICO

Population

Patients with acute rheumatic fever and chronic rheumatic heart disease, particularly children and young adults aged 5–24 years in low-resource settings

This review synthesizes current understanding of the immune-mediated pathogenesis of rheumatic heart disease to inform future experimental models, biomarker identification, and immunomodulatory therapies.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

May guide immune biomarker development for RHD; leaves open prospective validation of targeted therapies.

Cite This Study

Lupieri et al. (2026) conducted a review in Rheumatic heart disease. Antigenic mimicry and dysregulated immune control drive rheumatic heart disease immunopathogenesis through T-cell responses, cytokine dysregulation, endothelial activation, and stromal remodelling.

synapsesocial.com/papers/6a99051b555fc9bb84749458 https://doi.org/10.1016/j.lanmic.2026.101499

View Full Paper

Ask AI

Bookmark

Mechanisms underlying rheumatic heart disease immune-mediated pathogenesis: T-cell responses, cytokine networks, and immune dysregulation as drivers of valvular injury

Key Points

Structured PICO

Discussion

Implication

Cite This Study

Mechanisms underlying rheumatic heart disease immune-mediated pathogenesis: T-cell responses, cytokine networks, and immune dysregulation as drivers of valvular injury

Key Points

Structured PICO

Discussion

Implication

Cite This Study

Also Consider

Also Consider